Advertisement

Topics

Companies Related to "Citicoline Treatment of Methamphetamine Dependence" [Most Relevant Company Matches] RSS

13:17 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Citicoline Treatment of Methamphetamine Dependence" found in our extensive corporate database of over 50,000 company records.

Showing "Citicoline Treatment Methamphetamine Dependence" Companies 1–25 of 3,200+

Relevant

Catasys, Inc.

Catasys, Inc. provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through...


Hythiam, Inc.

Hythiam, Inc. provides through its Catasys subsidiary, specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs a...

Reckitt Benckiser Pharmaceuticals Inc.

Reckitt Benckiser Pharmaceuticals Inc. is a specialty pharmaceutical company that markets SUBOXONE(R) (buprenorphine HCl/naloxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C-III Sublingual Tablets and SUBUTEX(R) (buprenorphine HCl [2 mg and 8 mg]) C-III Sublingual Tablets, formulations of buprenorphine used to treat opioid dependence in a medical office-based setting. SUBOXONE(R) and SUBUTEX(R),...


Association for the Treatment of Tobacco Use and Dependence

The Partnership at Drugfree.org

The Partnership at Drugfree.org is a nonprofit organization that helps parents prevent, intervene in and find treatment for drug and alcohol use by their children. Bringing together renowned scientists, parent experts and communications professionals, the organization translates current research on teen behavior, addiction and treatment into easy to understand resources at drugfree.org. Through i...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is developing vigabatrin (designated CPP-109 by Catalyst) for the treatment of addiction to cocaine, methamphetamine and other addictive substances. The National Institute on Drug Abuse has stated that f...

Braeburn Pharmaceuticals

Braeburn Pharmaceuticals, an Apple Tree Partners company, develops and commercializes innovative medical products, with a focus on the field of addiction medicine. In December 2012, Braeburn licensed the development and commercialization rights for Probuphine®, a buprenorphine subdermal implant currently under development for the maintenance treatment o...

NuHope

Founded in 2018, NuHope is San Antonio’s new opiate only treatment center. Our outpatient clinic gives our patients the freedom to recover at home while combining medical care, physical rehabilitation, counseling, and responsibly reducing their dependence on opiates. It is important to us to that our patients are recovering as soon as possible with th...

Probably Relevant

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription an...

Alkane, Inc.

Alkane, Inc. is dedicated to the development and sales of alternative fuels and additives which reduce the cost of operating and maintaining vehicles. Additional benefits of Alkane, Inc.’s product offerings include positive environmental impact through the reduction of harmful emissions and a lessened U.S. dependence on foreign oil due to a decrease i...

Epik.com

Epik.com was founded in 2009 with a simple goal - to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. Epik.com is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions t...

Waismann Method

Performed in a hospital intensive care unit, the Waismann Method involves the administration of medications to reverse the physiological dependence on opiates while the symptoms of withdrawal are addressed. During the procedure, the patient experiences minimal conscious withdrawal, and will be able to return home within days. Seventy-five percent of the prescription drug dependent patients who ar...

BioMaxx Systems Inc.

"BioMaxx Systems Inc. is a biotechnology company that focuses on the development of innovative technology solutions to address the world's dependence on fossil fuels. The company creates solutions to produce clean fuels such as Ethanol - to promote clean, efficient alternatives that reduce harmful carbon dioxide emissions and greenhouse gases. BioMaxx Systems Inc., incorporated in 2001, provides p...

BioDelivery Sciences International, Inc.

BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. The Company is focusing on developing products to meet unmet patient needs ...

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions related to stress response that drive craving and relapse a...

ATUM

ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and production. ATUM exploits the dependence of biological activity on well-designed sequences. ATUM’s tools and solutions are fueling the transformation of biology from a...

CDEX, Inc.

CDEX is a technology development company, currently manufacturing and globally distributing advanced chemical detection products, based on its patented Enhanced Photoemission Spectroscopy technology. The company provides unique solutions to the challenges of identifying substances in difficult to monitor environments. CDEX technology is being adapted to market needs for medication validation, ...

Novocell, Inc.

Novocell is a preclinical therapeutic company focused on diabetes. Our therapy is based on the encapsulation and implantation of pancreatic beta cell progenitors (Pro-Islet-1) derived from human stem cells which secrete insulin in patients. Our goal is that Pro-Islet-1 can free both Type 1 and Type 2 diabetic patients from insulin dependence on a long term basis, while reducing or eliminating hy...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with ...

Pain Therapeutics

Pain Therapeutics, Inc. is a medical research company whose mission is to develop a new generation of opioid drugs (‘narcotic painkillers’). PTI has five active INDs and is focusing its Phase II development efforts on two lead compounds: MorViva™ - a substitute for morphine and other strong opioids, and OxyTrex™ - a substitute for oxycodone and other moderately strong opioids The Company h...

Syneron Medical

Syneron manufactures and sells non-ablative medical aesthetic devices that use the patented elos technology, the only combined energy system with applications for wrinkle treatment, skin treatment, cellulite reduction, acne treatment, Rosacea treatment, hair removal, leg vein and spider vein treatment, and more. elos technology, which combines Radio Frequency and Light energies is sold to dermatol...

Clinical Insights

Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become the gold standard in psychopharmacological clinical trials. Our Principal Investigator, Lawrence W. Adler, MD, has participated in the conduct of numerous clinical trials in psychiatric disorders since...

Cancer Treatment Centers of America, Inc.

Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Stand...

Meredian, Inc.

Meredian, Inc. is a privately held Georgia corporation which manufactures PHA biopolymers using renewable resources, further reducing the global dependence on petroleum historically used in production of plastics. Meredian, Inc. was formed by the principles following the success of its sister company, DaniMer Scientific, LLC. DaniMer Scientific was formed ...

Biotie Therapies

Biotie Therapies is a drug development biotechnology company with a focus on dependence disorders, inflammatory diseases and thrombosis.The most advanced drugs in development are nalmefene for alcoholism (phase III) and impulse control disorders (phase II), monoclonal VAP-1 antibody and small molecule VAP-1 SSAO enzyme inhibitor for inflammatory diseases (late preclinical), and recombinant biohepa...


More From BioPortfolio on "Citicoline Treatment of Methamphetamine Dependence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks